The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B

Table 1

Clinical characteristics of the 83 participators ().

Clinical characteristics	Control group ()	S0 group ()	S1 group ()	S2 group ()	S3 group ()	S4 group ()	CC group ()	DC group ()
Male/female	10/10	6/4	10/5	8/5	6/4	7/3	9/4	8/4
Age (years old)
Blood cell counts (10^9/L)
Hemoglobin (g/L)
Blood platelet (10^9/L)
ALT (U/L)
AST (U/L)
γ-GT (U/L)
ALP (U/L)
T-Bil (μmol/L)
D-Bil (μmol/L)
TP (g/L)
ALB (g/L)
TC (U/L)
TG (U/L)
AFP
INR
HBV-DNA (10^7 U/L)	—
HBeAg-positive rate (%)	—	30%	80%	58%	60%	40%	38%	33%

CC: compensated cirrhosis; DC: decompensated cirrhosis; CHB: chronic hepatitis B.